Evaluation of pregnancy outcomes in patients with multiple sclerosis after fingolimod exposure

BACKGROUND AND METHODS: Limited data are available on the safety of fingolimod in pregnant women. We estimated the risk of adverse pregnancy outcomes in women with multiple sclerosis (MS) exposed to fingolimod either shortly before or during pregnancy in prospectively collected cases from clinical t...

Descripción completa

Detalles Bibliográficos
Autores principales: Geissbühler, Yvonne, Vile, Jere, Koren, Gideon, Guennec, Morgane, Butzkueven, Helmut, Tilson, Hugh, MacDonald, Thomas M., Hellwig, Kerstin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6236588/
https://www.ncbi.nlm.nih.gov/pubmed/30542374
http://dx.doi.org/10.1177/1756286418804760

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6236588/
https://www.ncbi.nlm.nih.gov/pubmed/30542374
http://dx.doi.org/10.1177/1756286418804760

Ejemplares similares